研究者
J-GLOBAL ID：202101000916380120
更新日: 2025年02月10日 田中(佐々木) 玲奈
タナカ(ササキ) レイナ | SASAKI-TANAKA Reina
新潟大学大学院医歯学総合研究科 消化器内科
新潟大学大学院医歯学総合研究科 消化器内科 について
職名： 特任講師
ホームページURL (1件)： https://www.med.niigata-u.ac.jp/in3/about/staff.html
競争的資金等の研究課題 (1件)：
- 2023 - 2026 肝炎の重症化に関与するマイクロRNAの検討
- Tatsuo Kanda, Reina Sasaki-Tanaka, Shuji Terai. Combination therapies with immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma with major vascular invasion. Hepatology International. 2025
- Tatsuo Kanda, Reina Sasaki-Tanaka, Atsunori Tsuchiya, Shuji Terai. Hepatitis B virus infection and its treatment in Eastern Ethiopia. World Journal of Hepatology. 2025. 17. 1
- Tatsuo Kanda, Reina Sasaki-Tanaka, Shuji Terai. Inflammation of the liver, HCC development and HCC establishment. Hepatology International. 2024
- Tatsuo Kanda, Tian-Cheng Li, Masaharu Takahashi, Shigeo Nagashima, Putu Prathiwi Primadharsini, Satoshi Kunita, Reina Sasaki-Tanaka, Jun Inoue, Atsunori Tsuchiya, Shingo Nakamoto, et al. Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
- Tatsuo Kanda, Reina Sasaki-Tanaka, Shuji Terai. Liver Diseases: From Bench to Bedside. International Journal of Molecular Sciences. 2024. 25. 10. 5454
- Tatsuo Kanda, Shingo Nakamoto, Reina Sasaki, Yuki Haga, Masato Nakamura, Shin Yasui, Makoto Arai, Fumio Imazeki, Osamu Yokosuka. Assessment of serum hepatitis C virus RNA 24 weeks after the end of treatment using TaqMan PCR is more relevant than after 12 weeks for predicting sustained virological response by simeprevir-versus telaprevir-based triple therapy. HEPATOLOGY. 2015. 62. 807A-807A
- Tatsuo Kanda, Shingo Nakamoto, Reina Sasaki, Yuki Haga, Masato Nakamura, Shin Yasui, Makoto Arai, Fumio Imazeki, Osamu Yokosuka. Assessment of serum hepatitis C virus RNA 24 weeks after the end of treatment using TaqMan PCR is more relevant than after 12 weeks for predicting sustained virological response by simeprevir-versus telaprevir-based triple therapy. HEPATOLOGY. 2015. 62. 807A-807A
- Xia Jiang, Tatsuo Kanda, Shuang Wu, Yuki Haga, Reina Sasaki, Masato Nakamura, Shingo Nakamoto, Fumio Imazeki, Osamu Yokosuka. HCV NS5A blocks MG132-induced apoptosis in hepatocytes through the inhibition of NF-kappa B activation. HEPATOLOGY. 2014. 60. 647A-647A
- 博士(医学) (千葉大学)
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。
前のページに戻る
